-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Processa Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2016 to 2023.
- Processa Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 2.98M shares, a 122% increase year-over-year.
- Processa Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 1.31M shares, a 62.8% increase from 2022.
- Processa Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 805K shares.
- Processa Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2017 was 32.6M shares, a 11.2% increase from 2016.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)